After removing the tumors, the man’s urinary problems didn’t get worse, and a year later, the tumors hadn’t come back.
Scientific Claim
A 65-year-old man with neurofibromatosis type 2 and lower urinary tract symptoms had no evidence of tumor recurrence 1 year after transurethral resection and biopsy of pelvic schwannomas.
Original Statement
“After surgery, the patient experienced stability in his storage urinary symptoms and showed no signs of recurrence after 1 year of follow-up.”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
definitive
Can make definitive causal claims
Assessment Explanation
The claim reports a specific observation of no recurrence in one patient at 1 year — a factual outcome, not a generalization about recurrence rates.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Longitudinal Cohort StudyLevel 2bThe long-term recurrence rate of pelvic schwannomas after surgical excision in patients with neurofibromatosis type 2.
The long-term recurrence rate of pelvic schwannomas after surgical excision in patients with neurofibromatosis type 2.
What This Would Prove
The long-term recurrence rate of pelvic schwannomas after surgical excision in patients with neurofibromatosis type 2.
Ideal Study Design
A prospective cohort of 50 NF2 patients with surgically excised pelvic schwannomas, followed with annual MRI and clinical assessment for 10 years to document recurrence.
Limitation: Cannot determine if recurrence is due to incomplete resection or new tumor formation.
Case-Control StudyLevel 3Whether surgical excision reduces recurrence risk compared to observation in pelvic schwannomas.
Whether surgical excision reduces recurrence risk compared to observation in pelvic schwannomas.
What This Would Prove
Whether surgical excision reduces recurrence risk compared to observation in pelvic schwannomas.
Ideal Study Design
A case-control study comparing 40 patients with pelvic schwannomas who underwent surgery to 40 managed conservatively, matched for tumor size and location, with 5-year recurrence rates as the primary outcome.
Limitation: Cannot prove causation due to selection bias.
Evidence from Studies
Supporting (1)
A 65-year-old man had a rare benign tumor near his bladder and prostate, which was removed through a common procedure. The doctors found no signs the tumor came back, which matches what the claim says.